Personalized Medicine The purpose of this report is to describe the specific market segment of the diagnostics market called ...more

Market Study August 2007

The Future of Biosimilars: Key opportunities & emerging therapies The Future of Biosimilars: Key opportunities & emerging therapies is a marketing resource from ...more

Market Study August 2007

The Guide to Distributors of Medical Equipment & Supplies Worldwide 2007 (includes 4 regional volumes - also available for purchase separately) Fully expanded and updated with 1,600 detailed and verified profiles of specialist distributors in more ...more

Market Study July 2007

Regional Volume IV: Asia Pacfic Fully expanded and updated, Volume IV: Asia/Pacific contains over 320 detailed and fully verified ...more

Market Briefing July 2007

Regional Volume III: Americas Fully expanded and updated, Volume III: Americas contains over 370 detailed and fully verified profiles ...more

Market Briefing July 2007

Regional Volume II: Middle East Africa Fully expanded and updated, Volume II: Middle East/Africa contains over 320 detailed and fully verified ...more

Market Briefing July 2007

The Executive Guide to Molecular Imaging This report examines the background to the whole MI market, providing estimates and evaluation in key ...more

Market Briefing July 2007

Effectively Selling Medical Devices in Europe Understand the marketing and sales environment in Europe's leading markets! A wealth of ...more

Market Briefing July 2007

Cell Therapy Markets The study surveys almost all of the companies known to be marketing, manufacturing or developing ...more

Market Study July 2007

Drug Discovery Tools for High-Content Analysis The purpose of this examination is to describe the specific segments of the global drug discovery tools ...more

Market Study July 2007

New Cancer Drug Tracker: Satraplatin Long gone are the days when a drug successfully completing Phase III trials was virtually assured of ...more

Management Report June 2007

New Cancer Drug Tracker: Ixabepilone Long gone are the days when a drug successfully completing Phase III trials was virtually assured of ...more

Management Report June 2007

New Cancer Drug Tracker: Vatalanib Long gone are the days when a drug successfully completing Phase III trials was virtually assured of ...more

Management Report June 2007

New Cancer Drug Tracker: Telcyta Long gone are the days when a drug successfully completing Phase III trials was virtually assured of ...more

Management Report June 2007

Emerging Technologies in Spinal Motion Preservation “By 2011, motion preservation technologies will achieve revenues of US$5. ...more

Market Briefing June 2007

New Cancer Drug Tracker: Ticilimumab Long gone are the days when a drug successfully completing Phase III trials was virtually assured of ...more

Management Report June 2007